Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MassmedicaWAR:MSM +2.27%84 Market Cap is zł10.87 Mil as of Jul. 17, 2026. GuruFocus rates WAR:MSM with a GF Score™ of 84/100 and a GF Value™ of zł4.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Massmedica ranks worse than 94.23% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Massmedica's share price for the quarter that ended in Mar. 2026 was zł4.27. Massmedica's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 2.42 Mil. Therefore, Massmedica's market cap for the quarter that ended in Mar. 2026 was zł10.31 Mil.
Massmedica's quarterly market cap
increased
from Sep. 2025 (zł9.37 Mil) to Dec. 2025 (zł10.12 Mil) and
increased
from Dec. 2025 (zł10.12 Mil) to Mar. 2026 (zł10.31 Mil).
Massmedica's annual market cap
increased
from Dec. 2023 (zł5.94 Mil) to Dec. 2024 (zł12.20 Mil) but then
declined
from Dec. 2024 (zł12.20 Mil) to Dec. 2025 (zł10.12 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Massmedica's Enterprise Value for Today is zł19.04 Mil.
Massmedica (WAR:MSM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Massmedica Market Cap Related Terms
Massmedica Market Cap Historical Data
* Premium members only.
The historical data trend for Massmedica's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Massmedica's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Massmedica Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Massmedica's Market Cap distribution charts can be found below:
* The bar in red indicates where Massmedica's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Massmedica's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Massmedica (WAR:MSM) has a Market Cap of zł10.87 Mil as of Jul. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Massmedica and its competitors. According to the industry distribution chart, Massmedica ranks #816 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 94.2%.
Is Massmedica's Market Cap too high?
Massmedica's current Market Cap is zł10.87 Mil. Based on the distribution chart, Massmedica ranks #816 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Massmedica has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Massmedica's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Massmedica ranks #816 out of 866 companies for Market Cap. This places Massmedica in the lower half of its industry. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Massmedica and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Massmedica's current Market Cap is zł10.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Massmedica stock overvalued right now?
Based on GuruFocus' analysis, Massmedica (WAR:MSM) is currently considered Fairly Valued. The stock's GF Value™ is zł4.31, compared to a current price of zł4.50 — trading 4.4% above its estimated fair value. The current Market Cap is zł10.87 Mil. Massmedica's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Massmedica (WAR:MSM), the current Market Cap is zł10.87 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Massmedica (WAR:MSM) Overvalued in 2026?
Based on GuruFocus' analysis, Massmedica stock appears to be overvalued.
The current stock price of zł4.50 is trading 4.4% above its estimated GF Value™ of zł4.31.
GuruFocus considers Massmedica to be Fairly Valued.
Key valuation signals for WAR:MSM:
Market Cap: zł10.87 Mil
GF Value™: zł4.31 vs. price of zł4.50 (4.4% above fair value)
No single metric tells the full story. See the WAR:MSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Massmedica SA is operating in the areas of reconstructive, regenerative, anti-aging and aesthetic medicine. It deals in the distribution of implants and other medical materials used in the treatment of diseases of the musculoskeletal system and in regenerative medicine.
84GF Score
Get the complete analysis for WAR:MSM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MSM has been successfully added to your 
